Replies to post #406104 on Amarin Corp Plc (AMRN)

[golf stud]

Ok so $15 not unrealistic or higher to $20 plus with positive brave results

IMO mid 2024 could be an interesting time for this company

[Skipperdog11]

ziploc_1

"Even so ,I think AZ is so common and so devastating... and Vascepa so safe and relatively inexpensive that the FDA could approve it on an interim basis"

do you know if Amarin has any claim to this indication at the exclusion of other IPE encapsulators ? I just can't remember if the PTO has granted protection here. Thanks!

[JRoon71]

I think $10-15 is achievable without BRAVE (with lots of things going right).

But if BRAVE is very positive, then $20 would literally be the floor. I realize they probably can't get an indication out of the BRAVE study, but the mere fact that a study of that length and complexity (ie. spinal taps, etc.) showed positive results vs. ALZ would be enormous.

If it is only *mildly* positive, then I am not sure how much impact it will have. I think it needs to show some real significance.